Get the Stockscreener App
2.20
5.98%
-0.14
After Hours:
2.23
0.03
+1.36%
Medicus Pharma Ltd stock is traded at $2.20, with a volume of 278.84K.
It is down -5.98% in the last 24 hours and down -13.39% over the past month.
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.
See More
Previous Close:
$2.34
Open:
$2.29
24h Volume:
278.84K
Relative Volume:
0.74
Market Cap:
$50.21M
Revenue:
-
Net Income/Loss:
$-16.51M
P/E Ratio:
-1.6263
EPS:
-1.3528
Net Cash Flow:
$-15.68M
1W Performance:
-8.71%
1M Performance:
-13.39%
6M Performance:
-50.11%
1Y Performance:
+0.00%
1-Day Range:
$2.15
$2.35
1-Week Range:
$2.15
$2.5999
52-Week Range:
$1.7901
$8.94
Medicus Pharma Ltd Stock (MDCX) Company Profile
Name
Medicus Pharma Ltd
Sector
Industry
Phone
610-540-7515
Address
300 CONSHOHOCKEN STATE RD., W. CONSHOHOCKEN
Compare MDCX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDCX
Medicus Pharma Ltd
|
2.20 | 50.21M | 0 | -16.51M | -15.68M | -1.3528 |
|
LLY
Lilly Eli Co
|
906.86 | 802.41B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
186.86 | 448.76B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
215.89 | 374.44B | 59.64B | 2.37B | 18.24B | 1.331 |
|
NVS
Novartis Ag Adr
|
125.01 | 237.66B | 54.45B | 14.42B | 17.15B | 7.333 |
|
MRK
Merck Co Inc
|
83.86 | 206.04B | 63.99B | 19.05B | 14.72B | 7.5596 |
Medicus Pharma Ltd Stock (MDCX) Latest News
Applying Elliott Wave Theory to Medicus Pharma Ltd. Equity WarrantJuly 2025 Drop Watch & Comprehensive Market Scan Insights - newser.com
Will Medicus Pharma Ltd. stock benefit from commodity pricesLong Setup & Free Growth Oriented Trading Recommendations - newser.com
What MACD and RSI say about Medicus Pharma Ltd.Weekly Trend Summary & AI Forecasted Stock Moves - newser.com
How Medicus Pharma Ltd. (N460) stock behaves under inflation pressureTrend Reversal & Free Reliable Trade Execution Plans - newser.com
Will Medicus Pharma Ltd. Equity Warrant stock see insider buyingJuly 2025 Fed Impact & Consistent Profit Trading Strategies - newser.com
Medicus Pharma Ltd. Equity Warrant stock momentum explainedJuly 2025 Rallies & Comprehensive Market Scan Reports - newser.com
Technical signs of recovery in Medicus Pharma Ltd.Product Launch & Safe Entry Zone Tips - newser.com
Medicus Pharma Ltd. Announces First Patient Treated in United Arab Emirates (UAE) Sknjct-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin - The News Journal
How Medicus Pharma Ltd. (N460) stock reacts to monetary easingIndex Update & AI Forecasted Entry and Exit Points - newser.com
How strong is Medicus Pharma Ltd. Equity Warrant stock revenue growth2025 Market Trends & Detailed Earnings Play Strategies - newser.com
How resilient is Medicus Pharma Ltd. Equity Warrant stock in market downturnsMarket Sentiment Review & Free High Return Stock Watch Alerts - newser.com
How hedge fund analytics apply to Medicus Pharma Ltd. stockJuly 2025 Summary & Verified Technical Signals - newser.com
What risks investors should watch in Medicus Pharma Ltd. Equity Warrant stockFed Meeting & Safe Capital Growth Stock Tips - newser.com
Should you wait for a breakout in Medicus Pharma Ltd.Quarterly Earnings Report & Long Hold Capital Preservation Plans - newser.com
Is Medicus Pharma Ltd. Equity Warrant meeting your algorithmic filter criteria2025 Institutional Moves & Community Verified Swing Trade Signals - newser.com
Is Medicus Pharma Ltd. Equity Warrant stock supported by innovation pipelineVolume Spike & Weekly Watchlist for Consistent Profits - newser.com
How Medicus Pharma Ltd. Equity Warrant stock benefits from global expansionMarket Performance Summary & Weekly Breakout Stock Alerts - newser.com
Technical analysis overview for Medicus Pharma Ltd. Equity Warrant stockJuly 2025 Market Mood & Weekly High Potential Stock Alerts - newser.com
What drives Medicus Pharma Ltd Equity Warrant stock priceMarket Entry Points & Affordable Trading Techniques - earlytimes.in
Why Medicus Pharma Ltd. (N460) stock could be top winnerTrade Volume Report & Weekly Setup with ROI Potential - newser.com
Medicus Pharma Ltd. To Present at Brookline Capital Markets - Courier & Press
Chart based exit strategy for Medicus Pharma Ltd. Equity WarrantDip Buying & Advanced Swing Trade Entry Alerts - newser.com
Medicus Pharma eyes compassionate use approval of Skinject for Gorlin SyndromeICYMI - Proactive financial news
Why Medicus Pharma Ltd. Equity Warrant stock is favored by pension funds2025 Momentum Check & AI Enhanced Execution Alerts - newser.com
Is Medicus Pharma Ltd. Equity Warrant stock a safe buy before earningsJuly 2025 Selloffs & Risk Managed Investment Signals - newser.com
Medicus Pharma Ltd. Provides Update on United Arab Emirates (UAE) SKNJCT-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC) - The Holland Sentinel
Real time breakdown of Medicus Pharma Ltd. stock performanceDividend Hike & AI Enhanced Trade Execution Alerts - newser.com
Is Medicus Pharma Ltd. (N460) stock a fit for income portfoliosMarket Trend Report & Community Verified Watchlist Alerts - newser.com
Medicus Pharma Ltd. stock trendline breakdown2025 Key Highlights & Community Verified Swing Trade Signals - newser.com
Medicus Pharma Ltd Stock (MDCX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.88%
0.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):